Hydroxychloroquine Market Size, Outlook, Analysis Report, Regional Outlook With Forecast 2026

Hydroxychloroquine Market

Hydroxychloroquine, also referred to as hydroxychloroquine sulfate, possesses an immunosuppressive action with anti-viral characteristics. It is primarily prescribed for the treatment of infectious diseases such as malaria and auto-immune diseases such as lupus and rheumatoid arthritis.

Rising prevalence of such diseases, especially in Africa and Southeast Asia, provide an impetus to the market growth. As per the Centers for Disease Control and Prevention (CDC), in the U.S., around 1,500 cases and five malaria-related deaths are diagnosed each year. As per the World Health Organization’s World Malaria Report-2018, India registered around 4% of the global malaria cases and contributed about 87% to the total cases in Southeast Asia, further prompting the need for effective hydroxychloroquine.

The Major Players Covered in this Report:
Sandoz International Gmbh, Teva Pharmaceutical Industries Ltd., Mylan N.V., Hikma Pharmaceuticals Plc, Ipca Laboratories Limited, Shanghai Pharmaceutical Group Co., Ltd., Jiangsu Shenhua Pharmaceutical Co., Ltd., Sanofi S.A., Taj Pharmaceuticals Limited , Cinkate Corporation 

The hydroxychloroquine market was valued at USD 545.6 million in 2019 and is projected to grow with a CAGR of 32.8%.

Get a Sample PDF Report:
https://straitsresearch.com/report/Hydroxychloroquine-market/request-sample

By Type- USP standard grade, Pharmaceutical standard grade, EP Standards grade

By Application- Rheumatoid arthritis, Malaria, Systemic lupus erythematosus, COVID 19

Currently, the drug is witnessing a significant rise in demand for the treatment of COVID-19, which has created a health emergency and humanitarian crisis across the globe. Extensive research and clinical trials are performed to determine the efficacy of the drug before its commercialization as a treatment for COVID-19. Apart from this, the rising prevalence of infectious diseases, increasing health consciousness, advancements in the healthcare industry, surging R&D activities, and burgeoning healthcare expenditure drives the market growth. As per the National Health Expenditure Accounts (NHEA), in the U.S., the healthcare expenditure grew by 4.6% in 2018, accounting for about 17.7% of the country’s GDP.

Regional Analysis For Hydroxychloroquine Market:

North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

In this study, the years considered to estimate the market size of the Hydroxychloroquine are as follows:

• History Year: 2014-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2021 to 2026

The study objectives of this report are:

• To study and forecast the market size of the Hydroxychloroquine in the global market.
• To analyze the global key players, SWOT analysis, value, and global market share for top players.
• To define, describe and forecast the market by type, end-use, and region.
• To analyze and compare the market status and forecast among global major regions.
•  Analyze the potential of the global market and the advantages, opportunities and challenges, constraints, and risks of key regions.
• Identify the key trends and factors that are driving or holding back market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high-growth segments.
• Strategic analysis of each submarket in light of individual growth trends and market contributions.
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• Complete analysis of the strategic strategy and growth of key players

For More Details On this Report:
https://straitsresearch.com/report/Hydroxychloroquine-market

Contact Us:

Company Name: Straits Research
Email: sales@straitsresearch.com
Phone:
+1 646 480 7505 (U.S.)
+91 8087085354 (India)
+44 208 068 9665 (U.K.)

About Us:

Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches. This approach of using various research and analysis strategies enable us to determine greater insights by eliminating the research costs. Moreover, we're continually developing, not only with regards to where we measure, or who we measure but in how our visions can enable you to drive cost-effective growth.

This release was published on openPR.